My guess is that at the point of diagnosing HIE, physicians would administer 2591 to control neuroinflammtion and other symptoms. The baby is now in a critical condition and needs the same attention as an adult with stroke. What the dosage form will look like will be interesting, I'd have to assume it's an injectable solution or similar.
Regardless of the injury sustained (stroke or other brain tissue damage) 2591 should be applicable across the board and decrease the time to treatment. My hope is that 2591 can streamline the initial diagnosis and decrease time from birth to treatment:
"Baby is born, baby has low muscle tone or other visual symptoms. Ok administer 2591 while we perform MRIs to determine brain damage and confirm the diagnosis. Yep, HIE confirmed, let's keep the baby on treatment over the coming days". Or something like that.
- Forums
- ASX - By Stock
- Ann: Neuren initiates development of NNZ-2591 to treat HIE
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.04%
!
$17.11

My guess is that at the point of diagnosing HIE, physicians...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.11 |
Change
-0.180(1.04%) |
Mkt cap ! $2.190B |
Open | High | Low | Value | Volume |
$17.08 | $17.67 | $16.97 | $2.966M | 170.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 77 | $17.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.13 | 50 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 251 | 17.140 |
7 | 356 | 17.130 |
4 | 379 | 17.120 |
4 | 392 | 17.110 |
4 | 423 | 17.100 |
Price($) | Vol. | No. |
---|---|---|
17.170 | 71 | 4 |
17.180 | 169 | 2 |
17.190 | 363 | 3 |
17.200 | 425 | 5 |
17.210 | 479 | 5 |
Last trade - 11.38am 01/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |